00802: all contributions
2023–2024 · Reported individual contributions grouped by five-digit ZIP code.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to 00802Showing the last prepared contribution list. Updated records are not ready.
| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 341 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-11 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 342 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-26 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 343 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-11-02 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875041 · amendedFEC filing ↗ |
| 344 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-08 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 345 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPMENTAUVEN THERAPEUTICS | HMPC00495028 | 2024-10-16 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1866521 · amendedFEC filing ↗ |
| 346 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-23 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875041 · amendedFEC filing ↗ |
| 347 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-07-26 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875029 · amendedFEC filing ↗ |
| 348 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-18 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 349 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-12 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 350 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-10 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 351 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-08 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 352 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-11 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 353 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-20 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 354 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-15 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 355 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-10 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 356 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-11 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 357 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-09 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 358 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-26 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875041 · amendedFEC filing ↗ |
| 359 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-18 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 360 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-19 | $24 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
One page is fetched at a time, with one extra row to check for the next page. Current amendment versions are selected before pagination. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.